Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
Sven Marcel Stefan, Patric J. Jansson, Jens Pahnke, et al.
Scientific Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 76
Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-khalil, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 3, pp. 411-417
Open Access | Times Cited: 11
Functional and Structural Polypharmacology of Indazole-based Privileged Ligands to Tackle the Undruggability of Membrane Transporters
Sven Marcel Stefan, Sachin Puri, Muhammad Rafehi, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117234-117234
Open Access | Times Cited: 1
Computer-aided pattern scoring – A multitarget dataset-driven workflow to predict ligands of orphan targets
Katja Stefan, Vigneshwaran Namasivayam, Sven Marcel Stefan
Scientific Data (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Medicinal polypharmacology—a scientific glossary of terminology and concepts
Sven Marcel Stefan, Muhammad Rafehi
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure
Tushuai Li, Yue Gu, Baocai Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development
Sven Marcel Stefan, Muhammad Rafehi
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 15
New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
Feimu Fan, Joshua S. Fleishman, Chen Jin, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104069-104069
Closed Access | Times Cited: 5
Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
Sachin Puri, Katja Stefan, Sharuk L. Khan, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 657-676
Open Access | Times Cited: 20
Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics
Vigneshwaran Namasivayam, Katja Stefan, Lukáš Górecki, et al.
International Journal of Biological Macromolecules (2022) Vol. 217, pp. 775-791
Open Access | Times Cited: 19
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)
Jörg Haupenthal, Muhammad Rafehi, Andreas M. Kany, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Open Access | Times Cited: 4
A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development
Jingyun Wu, Luisa Möhle, Thomas Brüning, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14763-14763
Open Access | Times Cited: 18
The big data challenge – and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond
Sven Marcel Stefan, Muhammad Rafehi
Neural Regeneration Research (2023) Vol. 19, Iss. 8, pp. 1647-1648
Open Access | Times Cited: 10
HD_BPMDS: a curated binary pattern multitarget dataset of Huntington’s disease–targeting agents
Sven Marcel Stefan, Jens Pahnke, Vigneshwaran Namasivayam
Journal of Cheminformatics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Mobocertinib antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells: in vitro and in vivo studies
Xing-Duo Dong, Meng Zhang, Qiu‐Xu Teng, et al.
Cancer Letters (2024), pp. 217309-217309
Closed Access | Times Cited: 3
The Necessity for Polypharmacological Research – An Editorial on ‘Network Polypharmacology of ATP-binding Cassette (ABC) and Solute Carrier (SLC) Transporters’
Muhammad Rafehi, Kapil Juvale, Łukasz Pułaski, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa, Albert A. Antolín
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1043-1069
Closed Access | Times Cited: 2
Computer-aided pattern scoring (C@PS): a novel cheminformatic workflow to predict ligands with rare modes-of-action
Sven Marcel Stefan, Sven Marcel Stefan, Vigneshwaran Namasivayam
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer
Aayushi Gupta, Manu Smriti Singh, Bipin Singh
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Predictive, Integrative, and Regulatory Aspects of AI-Driven Computational Toxicology – Highlights of the German Pharm-Tox Summit (GPTS) 2024
Ute Haßmann, Steffen Amann, Nelly Babayan, et al.
Toxicology (2024) Vol. 509, pp. 153975-153975
Closed Access | Times Cited: 1
Structure–Selectivity Relationship Prediction of Tau Imaging Tracers Using Machine Learning-Assisted QSAR Models and Interaction Fingerprint Map
Maryam Gholampour, Hassan Seradj, Amirhossein Sakhteman
ACS Chemical Neuroscience (2023)
Closed Access | Times Cited: 1
Challenges in drug discovery and description targeting Leishmania spp.: enzymes, structural proteins, and transporters
Alexis Mendoza-León, María Luisa Serrano G., Alicia Ponte‐Sucre
Frontiers in Tropical Diseases (2023) Vol. 4
Open Access | Times Cited: 1
Gilteritinib reverses ABCB1-mediated multidrug resistance: Preclinical in vitro and animal investigations
Meng Zhang, Meiling She, Jun Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117603-117603
Open Access
Page 1

Scroll to top